Switch to:
More From Other Websites
ETFs with exposure to Achillion Pharmaceuticals, Inc. : April 25, 2017 Apr 25 2017
Why Achillion Pharmaceuticals Stock Sank on Monday Apr 25 2017
Today's Research Reports on Stocks to Watch: Achillion Pharmaceuticals and XOMA Apr 25 2017
Why Achillion Pharmaceuticals, Noble Corp., and RLJ Lodging Trust Slumped Today Apr 24 2017
Achillion Announces Additional Phase 2 Results Including 100% SVR24 for Genotype 1 HCV After 6-Weeks... Apr 22 2017
If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss Apr 20 2017
Achillion Announces Initiation of Patient Dosing in Phase 2 Study of ACH-4471 for Paroxysmal... Apr 06 2017
Today's Research Reports on Stocks to Watch: Achillion Pharmaceuticals and Corbus Pharmaceuticals Mar 31 2017
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US :... Mar 30 2017
Why Is Achillion (ACHN) Down 11.3% Since the Last Earnings Report? Mar 28 2017
USPTO Grants Composition of Matter Patent to Achillion for Small Molecule Complement Alternative... Mar 21 2017
Achillion Pharmaceuticals, Inc. :ACHN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 7, 2017 Mar 07 2017
Celldex Therapeutics (CLDX) Q4 Earnings: What's in Store? Mar 06 2017
These 5 Stocks Under $10 Could Explode Up Soon Mar 02 2017
Achillion Pharmaceuticals to Support a Natural History Study of C3 Glomerulopathy, a Rare Renal... Feb 28 2017
Achillion (ACHN) Reports Narrower-Than-Expected Q4 Loss Feb 27 2017
Biotech Movers: Cempra Flys High On Phase Three Results Feb 24 2017
Achillion Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACHN-US :... Feb 24 2017
Achillion reports 4Q loss Feb 23 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK